Can you provide the last earnings date for KARYOPHARM THERAPEUTICS INC?
KARYOPHARM THERAPEUTICS INC (KPTI) last reported earnings on 2/12/2026.
KARYOPHARM THERAPEUTICS INC (KPTI) Earnings History & Surprises
NASDAQ:KPTI • US48576U2050
Current stock price
6.66 USD
-0.97 (-12.71%)
At close:
6.3 USD
-0.36 (-5.41%)
Pre-Market:
KPTI Earnings overview
Past quarterly earnings results for KARYOPHARM THERAPEUTICS INC (KPTI), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$1.33
- Revenue Estimate
- 32.4M
Last Reported
Most Recent- Release Date
- Feb 12, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$2.22
- EPS Surprise
- -9.14%
- Revenue Surprise
- -4.84%
Beat Rate
Last 8 Quarters 56%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -2.22 | -2.03 | -9.14% | 38.33% | 34.079M | 35.814M | -4.84% | 11.58% |
| Q3 2025 | -3.82 | -3.19 | -19.63% | 2.05% | 44.044M | 42.036M | 4.78% | 13.57% |
| Q2 2025 | -4.32 | -4.18 | -3.34% | -292.00% | 37.929M | 37.674M | 0.68% | -11.35% |
| Q1 2025 | -2.77 | -4.26 | 35.04% | 42.29% | 30.015M | 35.947M | -16.50% | -9.39% |
| Q4 2024 | -3.60 | -4.00 | 10.00% | 33.33% | 30.542M | 35.562M | -14.12% | -9.50% |
| Q3 2024 | -3.90 | -4.02 | 3.03% | 13.33% | 38.783M | 38.544M | 0.62% | 7.70% |
| Q2 2024 | 2.25 | -4.57 | 149.25% | 151.72% | 42.786M | 36.903M | 15.94% | 13.86% |
| Q1 2024 | -4.80 | -5.11 | 6.03% | -6.67% | 33.126M | 35.162M | -5.79% | -14.40% |
| Q4 2023 | -5.40 | -4.74 | -13.96% | 16.28% | 33.747M | 36.113M | -6.55% | 0.44% |
| Q3 2023 | -4.50 | -4.28 | -5.04% | 33.33% | 36.009M | 38.025M | -5.30% | -0.25% |
| Q2 2023 | -4.35 | -5.24 | 16.92% | 53.23% | 37.579M | 36.736M | 2.29% | -5.34% |
| Q1 2023 | -4.50 | -5.63 | 20.12% | 43.40% | 38.698M | 37.337M | 3.65% | -18.87% |
| Q4 2022 | -6.45 | -5.40 | -19.42% | -193.48% | 33.6M | 35.821M | -6.20% | -73.40% |
| Q3 2022 | -6.75 | -8.65 | 21.99% | 34.78% | 36.1M | 35.253M | 2.40% | -4.24% |
| Q2 2022 | -9.30 | -9.69 | 4.02% | 12.68% | 39.7M | 36.303M | 9.36% | 75.66% |
| Q1 2022 | -7.95 | -9.65 | 17.65% | 31.17% | 47.7M | 34.854M | 36.86% | 104.72% |
| Q4 2021 | 6.90 | -7.89 | 187.47% | 177.97% | 126.3M | 40.868M | 209.04% | 259.83% |
| Q3 2021 | -10.35 | -10.30 | -0.47% | 5.48% | 37.7M | 26.32M | 43.24% | 77.00% |
| Q2 2021 | -10.65 | -11.46 | 7.07% | -12.70% | 22.6M | 26.153M | -13.59% | -32.54% |
| Q1 2021 | -11.55 | -10.88 | -6.17% | 1.28% | 23.3M | 25.672M | -9.24% | 28.73% |
| Q4 2020 | -8.85 | -9.06 | 2.29% | - | 35.1M | 29.961M | 17.15% | - |
| Q3 2020 | -10.95 | -11.06 | 1.01% | - | 21.3M | 21.882M | -2.66% | - |
| Q2 2020 | -9.45 | -8.89 | -6.31% | - | 33.5M | 27.97M | 19.77% | - |
| Q1 2020 | -11.70 | -10.61 | -10.23% | - | 18.1M | 21.708M | -16.62% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
0.74%
Max EPS beat (4)
35.04%
Min EPS beat (4)
-19.63%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-3.97%
Max Revenue beat (4)
4.78%
Min Revenue beat (4)
-16.50%
Analysis
In the last 4 quarters, KPTI has beaten EPS estimates in 1 out of 4 releases
KPTI has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, KPTI has beaten the EPS estimates by 0.7% on average.
In the last 4 quarters, KPTI reported -4.0% below the revenue estimates on average.
Related analysis
KARYOPHARM THERAPEUTICS INC / KPTI Earnings FAQ
Did KPTI stock beat earnings estimates in the most recent quarter?
KARYOPHARM THERAPEUTICS INC (KPTI) missed EPS estimates and missed revenue estimates in the most recent quarter.
How often does KARYOPHARM THERAPEUTICS INC (KPTI) beat earnings estimates?
In the last 4 quarters, KARYOPHARM THERAPEUTICS INC (KPTI) has beaten EPS estimates in 1 out of 4 releases.